Segui
Basant Amarji
Basant Amarji
Dr Reddys Laboratories, Hyderabad, India
Nessuna email verificata
Titolo
Citata da
Citata da
Anno
Novel dithranol phospholipid microemulsion for topical application: development, characterization and percutaneous absorption studies
K Raza, P Negi, S Takyar, A Shukla, B Amarji, OP Katare
Journal of microencapsulation 28 (3), 190-199, 2011
732011
Microemulsions mediated effective delivery of methotrexate hydrogel: more than a tour de force in psoriasis therapeutics
B Amarji, NK Garg, B Singh, OP Katare
Journal of drug targeting 24 (2), 147-160, 2016
522016
Efficacy of novel topical liposomal formulation of cyclosporine in mild to moderate stable plaque psoriasis: a randomized clinical trial
R Kumar, S Dogra, B Amarji, B Singh, S Kumar, S Sharma, K Vinay, ...
JAMA dermatology 152 (7), 807-815, 2016
502016
Synthesis, characterization and in vitro studies of pegylated melphalan conjugates
Ajazuddin, A Alexander, B Amarji, P Kanaujia
Drug development and industrial pharmacy 39 (7), 1053-1062, 2013
422013
Tamoxifen-loaded novel liposomal formulations: evaluation of anticancer activity on DMBA-TPA induced mouse skin carcinogenesis
A Bhatia, B Singh, K Raza, A Shukla, B Amarji, OP Katare
Journal of drug targeting 20 (6), 544-550, 2012
342012
Lipid nano spheres (LNSs) for enhanced oral bioavailability of amphotericin B: development and characterization
B Amarji, D Raghuwanshi, SP Vyas, P Kanaujia
Journal of Biomedical Nanotechnology 3 (3), 264-269, 2007
252007
Package development of pharmaceutical products: Aspects of packaging materials used for pharmaceutical products
B Amarji, A Kulkarni, PK Deb, R Maheshwari, RK Tekade
Dosage Form Design Parameters, 521-552, 2018
22*2018
Tamoxifen‐loaded liposomal topical formulation arrests hair growth in mice
A Bhatia, B Singh, B Amarji, OP Katare
British Journal of Dermatology 163 (2), 412-415, 2010
222010
Fabrication of acyclovir-loaded flexible membrane vesicles (FMVs): evidence of preclinical efficacy of antiviral activity in murine model of cutaneous HSV-1 infection
G Sharma, K Thakur, A Setia, B Amarji, MP Singh, K Raza, OP Katare
Drug Delivery and Translational Research 7, 683-694, 2017
192017
Dosage Form Design Considerations
PK Deb, O Al-Attraqchi, AY Jaber, B Amarji, RK Tekade
Elsevier, 2018
152018
Physicochemical aspects to be considered in pharmaceutical product development
PK Deb, O Al-Attraqchi, AY Jaber, B Amarji, RK Tekade
Dosage Form Design Considerations, 57-83, 2018
132018
Novel stain‐free lecithinized coal tar formulation for psoriasis
A Bhatia, B Singh, B Amarji, P Negi, A Shukla, OP Katare
International journal of dermatology 50 (10), 1246-1248, 2011
132011
Four stages of pharmaceutical product development: preformulation, prototype development and scale-up, biological aspects, and commercialization
B Amarji, SN Abed, U Bairagi, PK Deb, O Al-Attraqchi, AA Choudhury, ...
Dosage Form Design Considerations, 637-668, 2018
122018
Nano-bilosomes as potential vaccine delivery system for effective combined oral immunization against tetanus and hepatitis B
A Shukla, A Bhatia, B Amarji, B Singh, OP Katare, SP Vyas
Journal of biotechnology, 98-99, 2010
82010
Sharma; Vinay, K.; Mahajan, R.; Katare, OP Efficacy of novel topical liposomal formulation of cyclosporine in mild to moderate stable plaque psoriasis: A randomized clinical trial
R Kumar, S Dogra, B Amarji, B Singh, S Kumar
JAMA Dermatol 152 (7), 807-815, 2016
72016
Pluronic F127-tailored lecithin organogel of acyclovir: Preclinical evidence of antiviral activity using BALB/c murine model of cutaneous HSV-1 infection
G Sharma, B Kaur, K Thakur, A Mahajan, B Amarji, MP Singh, OP Katare
Drug Delivery and Translational Research 12, 213-228, 2022
62022
Topical oleaginous compositions
SK Dolai, B Amarji, PK Sasmal, NAK Ravipati, U Bairagi
US Patent App. 16/531,969, 2020
52020
DEEPIKA, Rahul MAHESHWARI a Rakesh K. TEKADE. Package Development of Pharmaceutical Products
B AMARJI, A KULKARNI, DEB Pran Kishore
Dosage Form Design Parameters, 521-552, 2018
52018
Stability and degradation studies for drug and drug product
R Maheshwari, P Todke, N Soni, N Raval, PK Deb, B Amarji, ...
Dosage Form Design Considerations, 225-257, 2018
52018
Lipid-based nanocarriers mediated Axitinib retinal delivery after topical instillation: Formulations setting up and in vivo evidence
E Zingale, A Bonaccorso, A Spadaro, C Carbone, T Musumeci, ...
Journal of Drug Delivery Science and Technology 100, 106026, 2024
2024
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20